Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,752.47
4,806.38
4,863.60
4,852.49
4,570.42
4,477.63
3,957.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,752.47
4,806.38
4,863.60
4,852.49
4,570.42
4,477.63
3,957.48
Raw Material Cost
4,424.25
4,494.98
4,574.25
4,577.53
4,326.05
4,243.65
3,734.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
110.00
98.83
99.53
97.59
90.38
76.96
75.93
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
68.60
71.57
51.15
47.66
55.71
40.98
38.97
Selling and Distribution Expenses
172.92
148.11
154.17
152.41
142.70
136.76
117.33
Other Expenses
-17.86
-17.04
-15.07
-14.52
-14.61
-11.79
-11.49
Total Expenditure (Excl Depreciation)
4,597.17
4,643.10
4,728.42
4,729.94
4,468.75
4,380.41
3,852.21
Operating Profit (PBDIT) excl Other Income
155.29999999999998
163.29999999999998
135.2
122.6
101.7
97.2
105.3
Other Income
-1.78
2.14
5.76
82.02
6.19
8.39
5.30
Operating Profit (PBDIT)
177.15
187.85
158.27
228.62
136.15
131.00
129.37
Interest
68.60
71.57
51.15
47.66
55.71
40.98
38.97
Exceptional Items
0.00
-0.03
-0.11
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
328.21
311.40
289.35
274.97
244.37
233.99
222.59
Depreciation
38.80
39.06
32.51
39.03
40.69
28.50
27.99
Profit Before Tax
69.75
77.19
74.50
141.93
39.75
61.51
62.42
Tax
19.56
19.42
17.76
36.73
11.84
15.94
16.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.18
57.77
56.74
105.21
27.90
45.57
45.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.18
57.77
56.74
105.21
27.90
45.57
45.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.18
57.77
56.74
105.21
27.90
45.57
45.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.11
1.06
1.1
1.12
0.0
1.19
1.12
Reserves
686.51
658.42
658.19
668.10
616.65
595.84
540.94
Earnings per share (EPS)
0.46
0.53
0.53
0.97
0.26
0.42
0.42
Diluted Earnings per share
0.46
0.53
0.53
0.97
0.26
0.42
0.42
Operating Profit Margin (Excl OI)
2.95%
3.05%
2.47%
2.22%
1.95%
2.1%
2.43%
Gross Profit Margin
2.28%
2.42%
2.2%
3.73%
1.76%
2.01%
2.28%
PAT Margin
1.06%
1.2%
1.17%
2.17%
0.61%
1.02%
1.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -1.12% vs -1.18% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -13.15% vs 1.94% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -3.66% vs 21.77% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -4.19% vs 39.84% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Charmacy Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
4,752.47
1,190.83
3,561.64
299.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,752.47
1,190.83
3,561.64
299.09%
Raw Material Cost
4,424.25
360.10
4,064.15
1,128.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
110.00
217.16
-107.16
-49.35%
Power Cost
0
0
0.00
Manufacturing Expenses
68.60
10.71
57.89
540.52%
Selling and Distribution Expenses
172.92
738.99
-566.07
-76.60%
Other Expenses
-17.86
-15.36
-2.50
-16.28%
Total Expenditure (Excl Depreciation)
4,597.17
1,173.34
3,423.83
291.80%
Operating Profit (PBDIT) excl Other Income
155.30
17.49
137.81
787.94%
Other Income
-1.78
23.42
-25.20
-107.60%
Operating Profit (PBDIT)
177.15
111.41
65.74
59.01%
Interest
68.60
10.71
57.89
540.52%
Exceptional Items
0.00
7.48
-7.48
-100.00%
Gross Profit (PBDT)
328.21
830.73
-502.52
-60.49%
Depreciation
38.80
70.49
-31.69
-44.96%
Profit Before Tax
69.75
37.68
32.07
85.11%
Tax
19.56
0.00
19.56
Provisions and contingencies
0
0
0.00
Profit After Tax
50.18
37.68
12.50
33.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50.18
37.68
12.50
33.17%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.18
37.68
12.50
33.17%
Equity Capital
0
0
0.00
Face Value
1.11
0.00
0.00
Reserves
686.51
776.51
-90.00
-11.59%
Earnings per share (EPS)
0.46
0.05
0.41
820.00%
Diluted Earnings per share
0.46
0.05
0.41
820.00%
Operating Profit Margin (Excl OI)
2.95%
1.47%
0.00
1.48%
Gross Profit Margin
2.28%
9.08%
0.00
-6.80%
PAT Margin
1.06%
3.16%
0.00
-2.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 475.25 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.12% vs -1.18% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 5.02 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -13.15% vs 1.94% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.89 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -3.66% vs 21.77% in Dec 2024
Annual - Interest
Interest 6.86 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -4.19% vs 39.84% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.95%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






